search
Back to results

Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis

Primary Purpose

Neurodermatitis

Status
Completed
Phase
Phase 3
Locations
Germany
Study Type
Interventional
Intervention
silver-contained textiles
corticosteroid
Sponsored by
University Medicine Greifswald
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neurodermatitis

Eligibility Criteria

2 Years - 70 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Clinical diagnosis of acute Neurodermitis Age: 2-70 years Patients are mobile Patient's information and willingness to participate Exclusion Criteria: Acute viral infection (herpes zoster, eczema herpeticum) Acute staphylodermas Other skin-diseases affecting outcomes of intervention (e.g. psoriasis) Current UV-Treatment Current other immunosuppressive or immunomodulated Therapy Current antimicrobial Therapy (e.g. antibiotics) Severe general diseases (e.g. melanoma, renal insufficiency, autoimmune diseases) Pregnancy Fertile females without effective contraception

Sites / Locations

  • Clinic and Polyclinic of Dermatology, Ernst-Moritz-Arndt-University of Greifswald

Outcomes

Primary Outcome Measures

SCORAD at days -3,0,7,14,28,56 for every group

Secondary Outcome Measures

Influence of silver containing textiles in reducing bacterial skin colonization (especially Staph. aureus)
Consumption of corticosteroids at days 0-28
Consumption of corticosteroids at days 28-56
Pruritus under textiles
Evaluation of quality of life

Full Information

First Posted
September 12, 2005
Last Updated
September 12, 2005
Sponsor
University Medicine Greifswald
Collaborators
Julius Zorn GmbH, Aichach, Germany
search

1. Study Identification

Unique Protocol Identification Number
NCT00196430
Brief Title
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
Official Title
Prospective, Controlled Three-Armed Study About Effectiveness and Compatibility of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2005
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2004 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
University Medicine Greifswald
Collaborators
Julius Zorn GmbH, Aichach, Germany

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to investigate whether the treatment of acute neurodermitis with silver-contained textiles is equivalent or more effective to the conservative exogenous treatment with a corticosteroid. Secondary aim is to define skin comfortability of the textiles.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neurodermatitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
Single
Allocation
Randomized
Enrollment
32 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
silver-contained textiles
Intervention Type
Drug
Intervention Name(s)
corticosteroid
Primary Outcome Measure Information:
Title
SCORAD at days -3,0,7,14,28,56 for every group
Secondary Outcome Measure Information:
Title
Influence of silver containing textiles in reducing bacterial skin colonization (especially Staph. aureus)
Title
Consumption of corticosteroids at days 0-28
Title
Consumption of corticosteroids at days 28-56
Title
Pruritus under textiles
Title
Evaluation of quality of life

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of acute Neurodermitis Age: 2-70 years Patients are mobile Patient's information and willingness to participate Exclusion Criteria: Acute viral infection (herpes zoster, eczema herpeticum) Acute staphylodermas Other skin-diseases affecting outcomes of intervention (e.g. psoriasis) Current UV-Treatment Current other immunosuppressive or immunomodulated Therapy Current antimicrobial Therapy (e.g. antibiotics) Severe general diseases (e.g. melanoma, renal insufficiency, autoimmune diseases) Pregnancy Fertile females without effective contraception
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Jünger, Prof. Dr.
Organizational Affiliation
Clinic and Polyclinic of Dermatology, University of Greifswald
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Andrea Ladwig
Organizational Affiliation
Clinic and Polyclinic of Dermatology, University of Greifswald
Official's Role
Study Chair
Facility Information:
Facility Name
Clinic and Polyclinic of Dermatology, Ernst-Moritz-Arndt-University of Greifswald
City
Greifswald
State/Province
Fleischmannstr. 42-44
ZIP/Postal Code
17475
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis

We'll reach out to this number within 24 hrs